Global Non-Steroidal Anti-Inflammatory Drugs Market Growth (Status and Outlook) 2026-2032
The global Non-Steroidal Anti-Inflammatory Drugs market size is predicted to grow from US$ 23330 million in 2025 to US$ 33830 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Non-Steroidal Anti-Inflammatory Drugs Industry Forecast? looks at past sales and reviews total world Non-Steroidal Anti-Inflammatory Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Steroidal Anti-Inflammatory Drugs sales for 2026 through 2032. With Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Steroidal Anti-Inflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Steroidal Anti-Inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Steroidal Anti-Inflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Steroidal Anti-Inflammatory Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Non-Steroidal Anti-Inflammatory Drugs Industry Forecast? looks at past sales and reviews total world Non-Steroidal Anti-Inflammatory Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Steroidal Anti-Inflammatory Drugs sales for 2026 through 2032. With Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Steroidal Anti-Inflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Steroidal Anti-Inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Steroidal Anti-Inflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Steroidal Anti-Inflammatory Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Non-Selective NSAIDs
- COX-2 Selective NSAIDs
- Dental Pain
- Muscle Aches
- Pain caused by Gout
- Bursitis
- Menstrual Cramps
- Fever
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Bayer AG
- GSK plc
- Dr. Reddy?s Laboratories Ltd
- Viatris Inc
- Teva Pharmaceutical Industries Ltd.
- Johnson And Johnson Services, Inc.
- Merck & Co., Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size (2021-2032)
2.1.2 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Country/Region (2021, 2025 & 2032)
2.2 Non-Steroidal Anti-Inflammatory Drugs Segment by Type
2.2.1 Non-Selective NSAIDs
2.2.2 COX-2 Selective NSAIDs
2.2.3 Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
2.2.3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
2.3 Non-Steroidal Anti-Inflammatory Drugs Segment by Application
2.3.1 Dental Pain
2.3.2 Muscle Aches
2.3.3 Pain caused by Gout
2.3.4 Bursitis
2.3.5 Menstrual Cramps
2.3.6 Fever
2.3.7 Others
2.3.8 Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
2.3.8.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.8.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE BY PLAYER
3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Player
3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2021-2026)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY REGION
4.1 Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.4 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.5 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
5.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
5.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026)
6.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
6.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs by Region (2021-2026)
8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET FORECAST
10.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.1.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.2 Canada Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.3 Mexico Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.4 Brazil Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.3.1 China Non-Steroidal Anti-Inflammatory Drugs Market Forecast
10.3.2 Japan Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.3 Korea Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.4 Southeast Asia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.5 India Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.6 Australia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.2 France Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.3 UK Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.4 Italy Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.5 Russia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.2 South Africa Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.3 Israel Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.4 Turkey Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.6 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Type (2027-2032)
10.7 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Steroidal Anti-Inflammatory Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 GSK plc
11.3.1 GSK plc Company Information
11.3.2 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GSK plc Main Business Overview
11.3.5 GSK plc Latest Developments
11.4 Dr. Reddy?s Laboratories Ltd
11.4.1 Dr. Reddy?s Laboratories Ltd Company Information
11.4.2 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.4.3 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dr. Reddy?s Laboratories Ltd Main Business Overview
11.4.5 Dr. Reddy?s Laboratories Ltd Latest Developments
11.5 Viatris Inc
11.5.1 Viatris Inc Company Information
11.5.2 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Viatris Inc Main Business Overview
11.5.5 Viatris Inc Latest Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Information
11.6.2 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.7 Johnson And Johnson Services, Inc.
11.7.1 Johnson And Johnson Services, Inc. Company Information
11.7.2 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Johnson And Johnson Services, Inc. Main Business Overview
11.7.5 Johnson And Johnson Services, Inc. Latest Developments
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Information
11.8.2 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck & Co., Inc. Main Business Overview
11.8.5 Merck & Co., Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size (2021-2032)
2.1.2 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Country/Region (2021, 2025 & 2032)
2.2 Non-Steroidal Anti-Inflammatory Drugs Segment by Type
2.2.1 Non-Selective NSAIDs
2.2.2 COX-2 Selective NSAIDs
2.2.3 Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
2.2.3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
2.3 Non-Steroidal Anti-Inflammatory Drugs Segment by Application
2.3.1 Dental Pain
2.3.2 Muscle Aches
2.3.3 Pain caused by Gout
2.3.4 Bursitis
2.3.5 Menstrual Cramps
2.3.6 Fever
2.3.7 Others
2.3.8 Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
2.3.8.1 Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.8.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE BY PLAYER
3.1 Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Player
3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2021-2026)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS BY REGION
4.1 Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.4 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.5 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
5.2 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
5.3 Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026)
6.2 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
6.3 APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs by Region (2021-2026)
8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET FORECAST
10.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.1.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast
10.1.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2 Americas Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.2 Canada Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.3 Mexico Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.2.4 Brazil Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3 APAC Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.3.1 China Non-Steroidal Anti-Inflammatory Drugs Market Forecast
10.3.2 Japan Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.3 Korea Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.4 Southeast Asia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.5 India Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.3.6 Australia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4 Europe Non-Steroidal Anti-Inflammatory Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.2 France Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.3 UK Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.4 Italy Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.4.5 Russia Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.2 South Africa Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.3 Israel Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.5.4 Turkey Market Non-Steroidal Anti-Inflammatory Drugs Forecast
10.6 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Type (2027-2032)
10.7 Global Non-Steroidal Anti-Inflammatory Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Steroidal Anti-Inflammatory Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 GSK plc
11.3.1 GSK plc Company Information
11.3.2 GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 GSK plc Main Business Overview
11.3.5 GSK plc Latest Developments
11.4 Dr. Reddy?s Laboratories Ltd
11.4.1 Dr. Reddy?s Laboratories Ltd Company Information
11.4.2 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.4.3 Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Dr. Reddy?s Laboratories Ltd Main Business Overview
11.4.5 Dr. Reddy?s Laboratories Ltd Latest Developments
11.5 Viatris Inc
11.5.1 Viatris Inc Company Information
11.5.2 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Viatris Inc Main Business Overview
11.5.5 Viatris Inc Latest Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Information
11.6.2 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.6.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.7 Johnson And Johnson Services, Inc.
11.7.1 Johnson And Johnson Services, Inc. Company Information
11.7.2 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Johnson And Johnson Services, Inc. Main Business Overview
11.7.5 Johnson And Johnson Services, Inc. Latest Developments
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Information
11.8.2 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
11.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck & Co., Inc. Main Business Overview
11.8.5 Merck & Co., Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Selective NSAIDs
Table 4. Major Players of COX-2 Selective NSAIDs
Table 5. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Table 8. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player (2021-2026)
Table 13. Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Products Offered
Table 14. Non-Steroidal Anti-Inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Table 19. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-Steroidal Anti-Inflammatory Drugs
Table 39. Key Market Challenges & Risks of Non-Steroidal Anti-Inflammatory Drugs
Table 40. Key Industry Trends of Non-Steroidal Anti-Inflammatory Drugs
Table 41. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Pfizer Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 46. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 47. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Pfizer Inc. Main Business
Table 49. Pfizer Inc. Latest Developments
Table 50. Bayer AG Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 51. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 52. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bayer AG Main Business
Table 54. Bayer AG Latest Developments
Table 55. GSK plc Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 56. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 57. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. GSK plc Main Business
Table 59. GSK plc Latest Developments
Table 60. Dr. Reddy?s Laboratories Ltd Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 61. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 62. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Dr. Reddy?s Laboratories Ltd Main Business
Table 64. Dr. Reddy?s Laboratories Ltd Latest Developments
Table 65. Viatris Inc Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 66. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 67. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Viatris Inc Main Business
Table 69. Viatris Inc Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 71. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 72. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Teva Pharmaceutical Industries Ltd. Main Business
Table 74. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 75. Johnson And Johnson Services, Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 76. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 77. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Johnson And Johnson Services, Inc. Main Business
Table 79. Johnson And Johnson Services, Inc. Latest Developments
Table 80. Merck & Co., Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 81. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 82. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Merck & Co., Inc. Main Business
Table 84. Merck & Co., Inc. Latest Developments
Table 1. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Steroidal Anti-Inflammatory Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Non-Selective NSAIDs
Table 4. Major Players of COX-2 Selective NSAIDs
Table 5. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Table 8. Non-Steroidal Anti-Inflammatory Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player (2021-2026)
Table 13. Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Products Offered
Table 14. Non-Steroidal Anti-Inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Table 19. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-Steroidal Anti-Inflammatory Drugs
Table 39. Key Market Challenges & Risks of Non-Steroidal Anti-Inflammatory Drugs
Table 40. Key Industry Trends of Non-Steroidal Anti-Inflammatory Drugs
Table 41. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Pfizer Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 46. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 47. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Pfizer Inc. Main Business
Table 49. Pfizer Inc. Latest Developments
Table 50. Bayer AG Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 51. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 52. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bayer AG Main Business
Table 54. Bayer AG Latest Developments
Table 55. GSK plc Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 56. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 57. GSK plc Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. GSK plc Main Business
Table 59. GSK plc Latest Developments
Table 60. Dr. Reddy?s Laboratories Ltd Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 61. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 62. Dr. Reddy?s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Dr. Reddy?s Laboratories Ltd Main Business
Table 64. Dr. Reddy?s Laboratories Ltd Latest Developments
Table 65. Viatris Inc Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 66. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 67. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Viatris Inc Main Business
Table 69. Viatris Inc Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 71. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 72. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Teva Pharmaceutical Industries Ltd. Main Business
Table 74. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 75. Johnson And Johnson Services, Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 76. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 77. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Johnson And Johnson Services, Inc. Main Business
Table 79. Johnson And Johnson Services, Inc. Latest Developments
Table 80. Merck & Co., Inc. Details, Company Type, Non-Steroidal Anti-Inflammatory Drugs Area Served and Its Competitors
Table 81. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product Offered
Table 82. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Merck & Co., Inc. Main Business
Table 84. Merck & Co., Inc. Latest Developments
LIST OF FIGURES
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2025)
Figure 8. Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type in 2025
Figure 10. Non-Steroidal Anti-Inflammatory Drugs in Dental Pain
Figure 11. Global Non-Steroidal Anti-Inflammatory Drugs Market: Dental Pain (2021-2026) & ($ millions)
Figure 12. Non-Steroidal Anti-Inflammatory Drugs in Muscle Aches
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs Market: Muscle Aches (2021-2026) & ($ millions)
Figure 14. Non-Steroidal Anti-Inflammatory Drugs in Pain caused by Gout
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs Market: Pain caused by Gout (2021-2026) & ($ millions)
Figure 16. Non-Steroidal Anti-Inflammatory Drugs in Bursitis
Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs Market: Bursitis (2021-2026) & ($ millions)
Figure 18. Non-Steroidal Anti-Inflammatory Drugs in Menstrual Cramps
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Market: Menstrual Cramps (2021-2026) & ($ millions)
Figure 20. Non-Steroidal Anti-Inflammatory Drugs in Fever
Figure 21. Global Non-Steroidal Anti-Inflammatory Drugs Market: Fever (2021-2026) & ($ millions)
Figure 22. Non-Steroidal Anti-Inflammatory Drugs in Others
Figure 23. Global Non-Steroidal Anti-Inflammatory Drugs Market: Others (2021-2026) & ($ millions)
Figure 24. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application in 2025
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player in 2025
Figure 26. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Figure 27. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 28. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 31. Americas Non-Steroidal Anti-Inflammatory Drugs Value Market Share by Country in 2025
Figure 32. United States Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region in 2025
Figure 37. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 38. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 39. China Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. India Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country in 2025
Figure 46. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. France Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 62. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 63. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 65. United States Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 66. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 67. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 68. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 69. China Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 70. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 71. Korea Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 73. India Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 74. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 75. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 76. France Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 77. UK Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 78. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 79. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 80. Egypt Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 81. South Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 82. Israel Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 83. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 84. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 1. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Steroidal Anti-Inflammatory Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2025)
Figure 8. Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type in 2025
Figure 10. Non-Steroidal Anti-Inflammatory Drugs in Dental Pain
Figure 11. Global Non-Steroidal Anti-Inflammatory Drugs Market: Dental Pain (2021-2026) & ($ millions)
Figure 12. Non-Steroidal Anti-Inflammatory Drugs in Muscle Aches
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs Market: Muscle Aches (2021-2026) & ($ millions)
Figure 14. Non-Steroidal Anti-Inflammatory Drugs in Pain caused by Gout
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs Market: Pain caused by Gout (2021-2026) & ($ millions)
Figure 16. Non-Steroidal Anti-Inflammatory Drugs in Bursitis
Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs Market: Bursitis (2021-2026) & ($ millions)
Figure 18. Non-Steroidal Anti-Inflammatory Drugs in Menstrual Cramps
Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Market: Menstrual Cramps (2021-2026) & ($ millions)
Figure 20. Non-Steroidal Anti-Inflammatory Drugs in Fever
Figure 21. Global Non-Steroidal Anti-Inflammatory Drugs Market: Fever (2021-2026) & ($ millions)
Figure 22. Non-Steroidal Anti-Inflammatory Drugs in Others
Figure 23. Global Non-Steroidal Anti-Inflammatory Drugs Market: Others (2021-2026) & ($ millions)
Figure 24. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application in 2025
Figure 25. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Player in 2025
Figure 26. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Figure 27. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 28. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2021-2026 ($ millions)
Figure 31. Americas Non-Steroidal Anti-Inflammatory Drugs Value Market Share by Country in 2025
Figure 32. United States Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region in 2025
Figure 37. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 38. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 39. China Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. India Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Country in 2025
Figure 46. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. France Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Non-Steroidal Anti-Inflammatory Drugs Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 62. APAC Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 63. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 65. United States Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 66. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 67. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 68. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 69. China Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 70. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 71. Korea Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 73. India Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 74. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 75. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 76. France Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 77. UK Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 78. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 79. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 80. Egypt Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 81. South Africa Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 82. Israel Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 83. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
Figure 84. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Non-Steroidal Anti-Inflammatory Drugs Market Size 2027-2032 ($ millions)
